THANK YOU to our current sponsors: Northside Hospital, Piedmont Hospital, The Pope Family, Northside Radiology, Steel Fab, Maxim Crane,Myriad Genetics, Cushman & Wakefield, ZeroRez, Eagle Vending, Whitlow Consulting, Triad, Strickland General Agency, Goldman Sachs, Strickland General Agency, ProPath, Atlanta Steel Erectors, Stanley D. Lindsey and Associates, and UPS!
THANK YOU to the Ladies PGA players who will be joining us at the tournament: Jennifer Neville, Megan Wallace, Erika Schneider, Kaylin Yoast, Melissa Siviter, AJ Newell, Sandra Angulo Minarro!
The Ovarian Cancer Institute is an innovative collaboration of noted gynecologic oncologist Benedict B. Benigno, M.D., and internationally recognized scientist John McDonald, Ph.D., Director of the Integrated Cancer Research Center at the Georgia Institute of Technology. Because of the relationship between Dr. Benigno and Dr. McDonald samples have been transfered from the operating room to the laboratory and over 2,000 ovarian cancer samples are now preserved, one of the largest sample banks and most extensive patient history database in the world.
OCI is not your traditional research institute. Often called a renegade, Dr. McDonald takes an "outside the box approach" to his work. Dr. McDonald integrates engineering, nanotechnology, medicine, computer science and chemistry to conduct his successful research. The laboratory uses an integrated systems approach to ovarian cancer research which only the Georgia Institute of Technology can provide.
The laboratory supported by OCI focuses on 3 major projects:
- personalized cancer genomics profiling, working toward prescribing optimal and personalized therapies for ovarian cancer patients
- targeted therapeutic delivery using nanotechnology
- diagnostic test for ovarian cancer in Stage I or sooner which has been proven 100% sensitive and specific!
These statistics motivate the Ovarian Cancer Institute to continue the fight through research. Early detection is vital to survival and now that a test has been discovered, we will continue through the validation stage and look forward to successful results.
The mission of the Ovarian Cancer Institute is to develop innovative research leading to earlier detection and more effective control of ovarian cancer; to investigate newer modalities of treatment; and to heighten women's awareness of the symptoms of, and treatment options for this disease.